Cetera Investment Advisers
CATX icon

Cetera Investment Advisers’s Perspective Therapeutics CATX Stock Holding History

Cetera Investment Advisers’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.8K Buy
+10,192
New +$38.5K ﹤0.01% 4805
2024
Q2 		– Sell
-1,250
Closed -$14.9K – 3747
2024
Q1 		$14.9K Buy
+1,250
New +$10.7K ﹤0.01% 3643
2023
Q4 		– Sell
-6,500
Closed -$17.8K – 2249
2023
Q3 		$17.8K Hold
6,500
– – ﹤0.01% 2162
2023
Q2 		$43.4K Sell
6,500
-2,000
-24% -$12.1K ﹤0.01% 2130
2023
Q1 		$54.2K Hold
8,500
– – ﹤0.01% 2089
2022
Q4 		$21K Buy
+8,500
New +$28K ﹤0.01% 2061

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Cetera Investment Advisers's CATX Position: Q2 2026 in Review

Cetera Investment Advisers opened a new position in Perspective Therapeutics (CATX) in Q2 2026: 10,192 shares worth $34.8K. The stake represents ﹤0.01% of the portfolio and ranks #4805 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in CATX as recently as Q1 2024.

Cetera Investment Advisers first reported a position in CATX in Q4 2022 and has held it in 6 quarters since. The position peaked at $54.2K in Q1 2023. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Cetera Investment Advisers held 10,192 shares of Perspective Therapeutics worth $34.8K as of Q2 2026.
  • Perspective Therapeutics was a new Cetera Investment Advisers position in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4805 holding.
  • Cetera Investment Advisers first reported a position in Perspective Therapeutics in Q4 2022 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Perspective Therapeutics position peaked at $54.2K in Q1 2023.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.